Stage IV Squamous Cell Carcinoma of the Nasopharynx Recruiting Phase 2 Trials for Cisplatin (DB00515)

IndicationStatusPhase
DBCOND0028783 (Stage IV Squamous Cell Carcinoma of the Nasopharynx)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00896181Phase 2 Sequential and Concurrent Chemoradiation for Advanced Nasopharyngeal Carcinoma (NPC)Treatment